In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists. The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites. The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.
France currently has about 80,000 ostomy patients. Stoma placement exposes patients to many surgical or peristomal skin complications which could impair the quality of life of the ostomy patient. The management of ostomy patients varies from institution to institution and according to how the patient's medical equipment is supplied as well as whether or not specialised personnel are available. In the last decade, the market for stoma therapy in France has evolved, with a significant increase in the delivery of equipment by HHNs, meeting a need for patient follow-up and accompaniment. This increased preference of HHNs to use specialist nurses seems to be explained by the added benefits. Early international studies have demonstrated the impact of an enterostomal therapy nurse follow-up on the improvement of ostomy patient's quality of life (QoL) relative to their health. However, none of the studies available today on follow-ups performed by an enterostomal therapist included the French population. Furthermore, the studies show methodological gaps, a limited time span and are based on strong hypotheses. In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists. The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites. The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
350
delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites
routine management of stoma
Hopital Bicètre
Le Kremlin-Bicêtre, France
Hopital Lyon-Sud
Lyon, France
Hopital SAint Louis
Paris, France
Hopital Saint-Louis
Paris, France
Hopital Saint-Antoine
Paris, France
Hopital de la Pitié-Salpétrière
Paris, France
Hopital HEGP
Paris, France
ESPIC FOCH - Digestige Unit
Suresnes, France
ESPIC Foch - Urology Unit
Suresnes, France
CHU Toulouse
Toulouse, France
Efficacy
score from the Stoma-QOL specific questionnaire (min: 0- max: 100), analysis of the mean
Time frame: 3 months
Satisfaction of patient
scale 0-100
Time frame: 3 and 6 months
Quality of life
Stoma-QOL questionnaire, (min: 0- max: 100), analysis of the mean
Time frame: 1, 2, 3 and 6 months
Quality of life
EQ-5D-5L questionnaire (min: 0- max: 1), analysis of the mean
Time frame: 1, 2, 3 and 6 months
Cost
• Calculation of resource use at 3 and 6 months per expenditure item (use of services, drug use, medical device and home healthcare service use, MCO (Médecine chirurgie obstétrique \[Obstetric surgery\]) hospitalisations and SSR (Soins de suite et de réadaptation \[Follow-up care and rehabilitation\]) hospitalisations) for each group.
Time frame: 3 and 6 months
Morbidity
readmission rate
Time frame: 3 and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.